Chaetospirolactone reverses the apoptotic resistance towards TRAIL in pancreatic cancer
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 495 (1) , 621-628
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonistApoptosis, 2010
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34Cancer Research, 2010
- Cytotoxic Chaetoglobosins from the EndophyteChaetomium globosumPlanta Medica, 2010
- TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5Journal of Molecular Medicine, 2010
- Polyhydroxylated steroids from an endophytic fungus, Chaetomium globosum ZY-22 isolated from Ginkgo bilobaSteroids, 2009
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonistsNature Reviews Drug Discovery, 2008
- The TRAIL apoptotic pathway in cancer onset, progression and therapyNature Reviews Cancer, 2008
- An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in miceHepatology, 2004
- Chemotherapeutic Agents Augment TRAIL-Induced Apoptosis in Human Hepatocellular Carcinoma Cell LinesHepatology, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999